Tag:

HIV

Latest Headlines

Latest Headlines

3-D vaccine triggers immune response against cancer and infections

Researchers at Harvard University have demonstrated that a nonsurgical injection of programmable biomaterial can assemble in vivo into a 3-D structure to attack cancer cells and help to prevent other infectious diseases such as HIV.

NIH grants $20M to develop an intravaginal ring to prevent HIV

The National Institutes of Health recently awarded $20 million to a collaboration of researchers led by the Oak Crest Institute of Science to develop a novel intravaginal ring designed to prevent the spread of sexually transmitted HIV in women by delivering powerful combinations of antiretroviral drugs.

Drug-loaded milk could offer oral HIV/AIDS prevention to children

HIV/AIDS prevention can be difficult in countries with limited resources, especially when it comes to the millions of affected children who are less likely to tolerate antiretroviral drugs. In an effort to overcome this challenge, researchers at Penn State University have developed a delivery system for the antiretroviral Ritonavir that uses a protein in cow's milk for oral administration of the drug.

Harvard investigators prep an animal study of CRISPR Cas tech for HIV

Investigators at Harvard say that they have successfully used CRISPR Cas gene-editing tools to come up with a new approach in curing HIV, a lethal virus that has claimed millions of lives over recent decades. And they're prepping for animal studies now to see if they can provide some preclinical proof-of-concept data to back up their lab experiment.

HIV hideout theory may not hold up

Investigators at Yerkes National Primate Research Center at Emory University may have found new evidence that dispels the theory that macrophages, a type of white blood cell, may harbor HIV for long periods of time, acting as a reservoir.

Protein discovery could help kill stubborn latent HIV

Researchers at the Salk Institute for Biological Studies have uncovered a protein that plays a role in active HIV replication, essentially acting as part of a switch to turn HIV-1, the most common type of HIV, from a dormant state to an active one.

Indian drugmakers scramble to prevent shortages of HIV/AIDS meds

Some Indian companies that had put off production of HIV/AIDS meds while they waited for the government to sign contracts are now having to seriously ramp up because of shortages of some meds, Reuters reports.

HIV spikes reveal clues for vaccine development

New technology has allowed researchers to view HIV proteins in action, zooming in on so-called spikes that help the virus bind to cells it infects. The research puts scientists one step closer to a vaccine that could effectively prevent transmission of HIV and halt the spread of AIDS, an international epidemic.

Gates Foundation funds monkey study of new HIV vaccine

Swiss firm Mymetics is getting a boost from the Bill and Melinda Gates Foundation to conduct a key animal study for its HIV vaccine candidate at the Texas Biomedical Research Institute.

Once-rejected drugs in Gilead's Stribild get FDA nod to go it alone

Gilead has been seeking FDA approval for HIV drugs Tybost and Vitekta for a while now, but the agency dealt the drugmaker a setback with Complete Response Letter last year. Now, 17 months later, the two have passed muster.